Method of modulating neurite outgrowth by the use of a galanin-3 receptor antagonist

Details for Australian Patent Application No. 2007265088 (hide)

Owner Helicon Therapeutics, Inc.

Inventors Blackburn, Thomas P.; Scott, Roderick E. M.

Agent Davies Collison Cave

Pub. Number AU-A-2007265088

PCT Pub. Number WO2008/002946

Priority 60/816,682 26.06.06 US

Filing date 26 June 2007

Wipo publication date 3 January 2008

International Classifications

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2008/002946 Priority application(s): WO2008/002946

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007265106-GRG33, GRG35, GRG36, GRG37, GRG38, GRG39, and GRG50: novel EPSP synthase genes conferring herbicide resistance

2007265077-Method and system for allowing a media player to transfer digital audio to an accessory